n-acetylcysteine a safe antidote for cysteine glutathione deficiency Clinical Applications N‐acetylcysteine as a new prominent

This primary immunodeficiency classically presents in late childhood or adolescence with recurrent, invasive infections caused by encapsulated Neisseria species, such as recurrent meningococcal meningitis or disseminated gonococcal infection

Psychedelics, but not ketamine, produce persistent antidepressant-like effects in a rodent experimental system for the study of depression

This primes TRM cells for rapid pathogen response while maintaining immune homeostasis (Feehan et al., 2024)

Weight loss was also assessed in the SCALE Sleep Apnea RCT, in which 359 non-diabetic individuals (mean age 48.5 years, mean BMI 39.1 kg/m 2 ), mostly males with untreated obstructive sleep apnea (OSA), were enrolled to investigate the effect of liraglutide on disease severity 20

The conventional chemically synthesized systems often showed unexpected immunogenicity, which is risky in clinical administration